Literature DB >> 22083890

Interaction of hesperetin glucuronide conjugates with human BCRP, MRP2 and MRP3 as detected in membrane vesicles of overexpressing baculovirus-infected Sf9 cells.

Walter Brand1, Berend Oosterhuis, Peter Krajcsi, Denis Barron, Fabiola Dionisi, Peter J van Bladeren, Ivonne M C M Rietjens, Gary Williamson.   

Abstract

The citrus flavonoid hesperetin (4'-methoxy-3',5,7-trihydroxyflavanone) is the aglycone of hesperidin, the major flavonoid present in sweet oranges. Hesperetin 7-O-glucuronide (H7G) and hesperetin 3'-O-glucuronide (H3'G) are the two most abundant metabolites of hesperetin in vivo. In this study, their interaction with specific ABC transporters, believed to play a role in the disposition and bioavailability of hesperetin, was studied using Sf9 membranes from cells overexpressing human BCRP (ABCG2), MRP2 (ABCC2) and MRP3 (ABCC3). Both H7G and H3'G were tested for their potential to activate and inhibit ATPase activity, and to inhibit vesicular transport by these transporters. Both H7G and H3'G demonstrated interaction with all tested ABC transporters, especially with BCRP and MRP3. An interesting difference between H7G and H3'G was seen with respect to the interaction with BCRP: H7G stimulated the ATPase activity of BCRP up to 76% of the maximal effect generated by the reference activator sulfasalazine, with an EC(50) of 0.45 µM, suggesting that H7G is a high affinity substrate of BCRP, whereas H3'G did not stimulate BCRP ATPase activity. Only moderate inhibition of BCRP ATPase activity at high H3'G concentrations was observed. This study provides information on the potential of hesperetin glucuronide conjugates to act as specific ABC transporter substrates or inhibitors and indicates that regio-specific glucuronidation could affect the disposition of hesperetin.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22083890     DOI: 10.1002/bdd.780

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  5 in total

1.  Identification of potent inhibitors of NEK7 protein using a comprehensive computational approach.

Authors:  Mubashir Aziz; Syeda Abida Ejaz; Nissren Tamam; Farhan Siddique; Naheed Riaz; Faizan Abul Qais; Samir Chtita; Jamshed Iqbal
Journal:  Sci Rep       Date:  2022-04-18       Impact factor: 4.996

2.  Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells.

Authors:  Yong Yang; Joy Wolfram; Kathryn Boom; Xiaohong Fang; Haifa Shen; Mauro Ferrari
Journal:  Cell Biochem Funct       Date:  2012-10-08       Impact factor: 3.685

3.  Curcumin Affects Phase II Disposition of Resveratrol Through Inhibiting Efflux Transporters MRP2 and BCRP.

Authors:  Shufan Ge; Taijun Yin; Beibei Xu; Song Gao; Ming Hu
Journal:  Pharm Res       Date:  2015-10-26       Impact factor: 4.200

4.  Chronic exposure to short-chain fatty acids modulates transport and metabolism of microbiome-derived phenolics in human intestinal cells.

Authors:  Evelien Van Rymenant; László Abrankó; Sarka Tumova; Charlotte Grootaert; John Van Camp; Gary Williamson; Asimina Kerimi
Journal:  J Nutr Biochem       Date:  2016-09-30       Impact factor: 6.048

5.  Engineering a passivating electric double layer for high performance lithium metal batteries.

Authors:  Weili Zhang; Yang Lu; Lei Wan; Pan Zhou; Yingchun Xia; Shuaishuai Yan; Xiaoxia Chen; Hangyu Zhou; Hao Dong; Kai Liu
Journal:  Nat Commun       Date:  2022-04-19       Impact factor: 17.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.